WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:WELL-DB - CA94947LAC69
100 CAD
0 (0%)
Taking everything into account, WELL-DB scores 3 out of 10 in our fundamental rating. WELL-DB was compared to 14 industry peers in the Health Care Providers & Services industry. WELL-DB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WELL-DB is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year WELL-DB has reported negative net income.
WELL-DB had a negative operating cash flow in the past year.
In multiple years WELL-DB reported negative net income over the last 5 years.
Of the past 5 years WELL-DB 4 years had a positive operating cash flow.
1.2 Ratios
WELL-DB's Return On Assets of -2.14% is on the low side compared to the rest of the industry. WELL-DB is outperformed by 64.29% of its industry peers.
With a Return On Equity value of -5.12%, WELL-DB perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 39.97%, WELL-DB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
WELL-DB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for WELL-DB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WELL-DB has been increased compared to 1 year ago.
WELL-DB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, WELL-DB has an improved debt to assets ratio.
2.2 Solvency
WELL-DB has an Altman-Z score of 13.52. This indicates that WELL-DB is financially healthy and has little risk of bankruptcy at the moment.
WELL-DB's Altman-Z score of 13.52 is amongst the best of the industry. WELL-DB outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that WELL-DB is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.67, WELL-DB is doing good in the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.52 |
ROIC/WACCN/A
WACC7.73%
2.3 Liquidity
A Current Ratio of 0.92 indicates that WELL-DB may have some problems paying its short term obligations.
WELL-DB has a better Current ratio (0.92) than 71.43% of its industry peers.
WELL-DB has a Quick Ratio of 0.92. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, WELL-DB is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for WELL-DB have decreased strongly by -200.00% in the last year.
Looking at the last year, WELL-DB shows a very strong growth in Revenue. The Revenue has grown by 26.20%.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
3.2 Future
Based on estimates for the next years, WELL-DB will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.72% on average per year.
WELL-DB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.80% yearly.
EPS Next Y181.06%
EPS Next 2Y66.97%
EPS Next 3Y42.44%
EPS Next 5Y19.72%
Revenue Next Year41.58%
Revenue Next 2Y25.55%
Revenue Next 3Y18.77%
Revenue Next 5Y15.8%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WELL-DB. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 239.12 indicates a quite expensive valuation of WELL-DB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WELL-DB is on the same level as its industry peers.
WELL-DB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 239.12 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, WELL-DB is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 284.53 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
WELL-DB's earnings are expected to grow with 42.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.97%
EPS Next 3Y42.44%
5. Dividend
5.1 Amount
WELL-DB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:WELL-DB (12/12/2025, 7:00:00 PM)
100
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.3%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap25.39B
Revenue(TTM)1.21B
Net Income(TTM)-43.25M
Analysts81
Price Target195.56 (95.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.08%
Min EPS beat(2)-41.18%
Max EPS beat(2)-32.99%
EPS beat(4)0
Avg EPS beat(4)-244.03%
Min EPS beat(4)-696.08%
Max EPS beat(4)-32.99%
EPS beat(8)2
Avg EPS beat(8)1902.08%
EPS beat(12)3
Avg EPS beat(12)1068.91%
EPS beat(16)3
Avg EPS beat(16)736.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-1.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)3
Avg Revenue beat(8)-1.47%
Revenue beat(12)5
Avg Revenue beat(12)-0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)29%
PT rev (3m)18.93%
EPS NQ rev (1m)5.61%
EPS NQ rev (3m)36.97%
EPS NY rev (1m)30.98%
EPS NY rev (3m)1376.18%
Revenue NQ rev (1m)-1.87%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 239.12 | ||
| P/S | 21.01 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 30.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 284.53 |
EPS(TTM)-0.12
EYN/A
EPS(NY)0.42
Fwd EY0.42%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.76
BVpS3.33
TBVpS-2.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score1
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.23 | ||
| Cap/Depr | 27.43% | ||
| Cap/Sales | 2.1% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 13.52 |
F-Score1
WACC7.73%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y181.06%
EPS Next 2Y66.97%
EPS Next 3Y42.44%
EPS Next 5Y19.72%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
Revenue Next Year41.58%
Revenue Next 2Y25.55%
Revenue Next 3Y18.77%
Revenue Next 5Y15.8%
EBIT growth 1Y-102.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.58%
EBIT Next 3Y64.26%
EBIT Next 5Y47.63%
FCF growth 1Y-170.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.25%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES / WELL-DB.CA FAQ
What does WELL-DB do?
WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. The company is headquartered in Vancouver, British Columbia and currently employs 3,200 full-time employees. The company went IPO on 2012-12-17. Its healthcare and digital platform includes front and back-office management software applications that help physicians. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. The Canadian Patient Services segment provides primary care and allied health clinic operations in Canada and specialty care and accredited diagnostic health services from WDC. The WELL Health USA Patient and Provider Services segment includes U.S. primary care telehealth operations from Circle Medical; U.S. primary care operations from WISP; specialized care gastroenterology anesthesia services, and specialized medical recruitment and staffing services. The SaaS and Technology Services segment includes aggregation of electronic medical records, billing and revenue cycle management solutions, digital applications, and cybersecurity operating segments.
What is the current price of WELL-DB stock?
The current stock price of WELL-DB.CA is 100 CAD.
How is the ChartMill rating for WELL HEALTH TECHNOLOGIES?
WELL-DB.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is WELL HEALTH TECHNOLOGIES (WELL-DB.CA) stock traded?
WELL-DB.CA stock is listed on the Toronto Stock Exchange exchange.